Skip to main content
logo
Entheon Biomedical Corp. (CSE:ENBI.X)
Canada flag Canada · Delayed Price · Currency is CAD
0.0600
0.00 (0.00%)
At close: Sep 2, 2026

Entheon Biomedical Financials Overview

Millions CAD. Fiscal year is Dec - Nov.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Revenue
---0.250.19-
Revenue Growth
---31.97%--
Gross Profit
---0.250.19-
Operating Income
-0.32-0.33-0.33-0.31-3.6-8.21
Net Income
0.04-0.32-0.32-0.3-8.52-8.89
Earnings Per Share
0.00-0.02-0.04-0.05-1.44-1.64
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Cash & Investments
0.320.320.140.340.682.05
Total Debt
------
Net Cash (Debt)
0.320.320.140.340.682.05
Net Cash Growth
-20.78%135.79%-60.39%-49.33%-66.81%-27.77%
Net Cash Per Share
0.020.020.020.060.120.38

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Operating Cash Flow
-0.09-0.31-0.36-0.36-1.95-5.33
Capital Expenditures
------
Free Cash Flow
-0.09-0.31-0.36-0.36-1.95-5.33
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Gross Margin
---100.00%100.00%-
Operating Margin
----124.96%-1898.18%-
Pretax Margin
----119.85%-1086.83%-
Profit Margin
----119.85%-4492.23%-
FCF Margin
----143.79%-1030.49%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
PS Ratio
---2.369.35-